112 related articles for article (PubMed ID: 1655518)
41. Interleukin-6 inhibits the potent stimulatory action of androgens, glucocorticoids and interleukin-1 alpha on apolipoprotein D and GCDFP-15 expression in human breast cancer cells.
Blais Y; Sugimoto K; Carrière MC; Haagensen DE; Labrie F; Simard J
Int J Cancer; 1995 Sep; 62(6):732-7. PubMed ID: 7558422
[TBL] [Abstract][Full Text] [Related]
42. Analysis of thymic stromal cell subpopulations grown in vitro on extracellular matrix in defined medium--V. Proliferation regulating activities in supernatants of human thymic epithelial cell cultures.
Meilin A; Sharabi Y; Shoham J
Int J Immunopharmacol; 1997 Jan; 19(1):39-47. PubMed ID: 9226478
[TBL] [Abstract][Full Text] [Related]
43. Constitutive secretion of hematopoietic cytokines by human carcinoma cell lines and its up-regulation by interleukin-1 and phorbol ester.
Steube KG; Meyer C; Drexler HG
Oncol Rep; 1999; 6(2):427-32. PubMed ID: 10023015
[TBL] [Abstract][Full Text] [Related]
44. Human Umbilical Cord Mesenchymal Stem Cells Promote Breast Cancer Metastasis by Interleukin-8- and Interleukin-6-Dependent Induction of CD44(+)/CD24(-) Cells.
Ma F; Chen D; Chen F; Chi Y; Han Z; Feng X; Li X; Han Z
Cell Transplant; 2015; 24(12):2585-99. PubMed ID: 25695620
[TBL] [Abstract][Full Text] [Related]
45. Phorbol ester enhancement of IL-3-dependent proliferation of primitive hematopoietic progenitors of mice in culture.
Musashi M; Sakurada K; Kawamura K; Iwasaki H; Tsuda Y; Kobayashi M; Sasaki M; Kato K; Tanaka E; Sudo T; Asaka M; Miyazaki T
J Pharmacol Exp Ther; 1997 Jan; 280(1):225-31. PubMed ID: 8996200
[TBL] [Abstract][Full Text] [Related]
46. Ginsenoside Rh2 Ameliorates Doxorubicin-Induced Senescence Bystander Effect in Breast Carcinoma Cell MDA-MB-231 and Normal Epithelial Cell MCF-10A.
Hou JG; Jeon BM; Yun YJ; Cui CH; Kim SC
Int J Mol Sci; 2019 Mar; 20(5):. PubMed ID: 30871042
[TBL] [Abstract][Full Text] [Related]
47. Enhanced expression of human T-cell leukemia/lymphoma virus in neoplastic T cells induced to proliferate by phorbol ester and interleukin-2.
Vyth-Dreese FA; de Vries JE
Int J Cancer; 1983 Jul; 32(1):53-9. PubMed ID: 6602780
[TBL] [Abstract][Full Text] [Related]
48. Differential effects of epidermal growth factor and interleukin 6 on corneal epithelial cells and vascular endothelial cells.
Nakamura M; Nishida T
Cornea; 1999 Jul; 18(4):452-8. PubMed ID: 10422859
[TBL] [Abstract][Full Text] [Related]
49. Induction of 3beta-hydroxysteroid dehydrogenase/isomerase type 1 expression by interleukin-4 in human normal prostate epithelial cells, immortalized keratinocytes, colon, and cervix cancer cell lines.
Gingras S; Simard J
Endocrinology; 1999 Oct; 140(10):4573-84. PubMed ID: 10499513
[TBL] [Abstract][Full Text] [Related]
50. Intracellular FGF-2 promotes differentiation in T-47D breast cancer cells.
Korah RM; Sysounthone V; Scheff E; Wieder R
Biochem Biophys Res Commun; 2000 Oct; 277(1):255-60. PubMed ID: 11027671
[TBL] [Abstract][Full Text] [Related]
51. Nuclear factor kappa B (NF-kappa B), nuclear factor interleukin-6 (NFIL-6 or C/EBP beta) and nuclear factor interleukin-6 beta (NFIL6-beta or C/EBP delta) are not sufficient to activate the endogenous interleukin-6 gene in the human breast carcinoma cell line MCF-7. Comparative analysis with MDA-MB-231 cells, an interleukin-6-expressing human breast carcinoma cell line.
Faggioli L; Costanzo C; Merola M; Bianchini E; Furia A; Carsana A; Palmieri M
Eur J Biochem; 1996 Aug; 239(3):624-31. PubMed ID: 8774705
[TBL] [Abstract][Full Text] [Related]
52. Phorbol ester and bryostatin effects on growth and the expression of oestrogen responsive and TGF-beta 1 genes in breast tumour cells.
Nutt JE; Harris AL; Lunec J
Br J Cancer; 1991 Oct; 64(4):671-6. PubMed ID: 1911215
[TBL] [Abstract][Full Text] [Related]
53. Interleukin-6 stimulates motility of vascular endothelium.
Rosen EM; Liu D; Setter E; Bhargava M; Goldberg ID
EXS; 1991; 59():194-205. PubMed ID: 1833229
[TBL] [Abstract][Full Text] [Related]
54. Estrogen promotes reversible epithelial-to-mesenchymal-like transition and collective motility in MCF-7 breast cancer cells.
Planas-Silva MD; Waltz PK
J Steroid Biochem Mol Biol; 2007 Apr; 104(1-2):11-21. PubMed ID: 17197171
[TBL] [Abstract][Full Text] [Related]
55. Characterization of the effects of the novel non-steroidal antiestrogen EM-800 on basal and estrogen-induced proliferation of T-47D, ZR-75-1 and MCF-7 human breast cancer cells in vitro.
Simard J; Labrie C; Bélanger A; Gauthier S; Singh SM; Mérand Y; Labrie F
Int J Cancer; 1997 Sep; 73(1):104-12. PubMed ID: 9334816
[TBL] [Abstract][Full Text] [Related]
56. Insulin receptor expression and function in human breast cancer cell lines.
Milazzo G; Giorgino F; Damante G; Sung C; Stampfer MR; Vigneri R; Goldfine ID; Belfiore A
Cancer Res; 1992 Jul; 52(14):3924-30. PubMed ID: 1617668
[TBL] [Abstract][Full Text] [Related]
57. The anti-proliferative effect of suramin towards tamoxifen-sensitive and resistant human breast cancer cell lines in relation to expression of receptors for epidermal growth factor and insulin-like growth factor-I: growth stimulation in the presence of tamoxifen.
Boylan M; van den Berg HW; Lynch M
Ann Oncol; 1998 Feb; 9(2):205-11. PubMed ID: 9553667
[TBL] [Abstract][Full Text] [Related]
58. Genetic instability and the development of steroid hormone insensitivity in cultured T 47D human breast cancer cells.
Reddel RR; Alexander IE; Koga M; Shine J; Sutherland RL
Cancer Res; 1988 Aug; 48(15):4340-7. PubMed ID: 3390830
[TBL] [Abstract][Full Text] [Related]
59. Secretory products of breast cancer cells specifically affect human osteoblastic cells: partial characterization of active factors.
Siwek B; Lacroix M; De Pollak C; Marie P; Body JJ
J Bone Miner Res; 1997 Apr; 12(4):552-60. PubMed ID: 9101366
[TBL] [Abstract][Full Text] [Related]
60. Specific and non-specific KGF inhibition of KGF-induced breast cancer cell motility.
Zang XP; Nguyen TN; Pento JT
Anticancer Res; 2002; 22(5):2539-45. PubMed ID: 12529961
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
